The limited MBNL1 availability leads to the aberrant regulation of alternative splicing of hundreds of genes, causing various clinical manifestations such as progressive muscle wasting, myotonia, insulin resistance, cardiac arrhythmia, cataracts, and intellectual deficits [5]. Here, MBNL1 is linked to Myotonia.